Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3265121000168112 | durvalumab (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3265131000168110 | durvalumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| durvalumab | Is a | medicinal product | true | Inferred relationship | Some | ||
| durvalumab | has intended active ingredient | durvalumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| durvalumab 120 mg/2.4 mL injection, vial | Is a | True | durvalumab | Inferred relationship | Some | |
| durvalumab 500 mg/10 mL injection, vial | Is a | True | durvalumab | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR